This is a community-generated profile. If you work at Covagen, to claim it.
View 0 jobs

Covagen careers

Covagen develops bispecific FynomAbs by fusing its human Fynomer binding proteins to antibodies, resulting in therapeutics with novel modes of action and enhanced efficacy in the treatment of inflammatory diseases and cancer. The ability to fuse Fynomers to multiple sites on an antibody allows Covagen to create FynomAbs with tailored architectures to maximize efficacy. Their goal is to access novel biology for each product candidate. Covagen’s lead FynomAb COVA322 is being developed for the treatment of inflammatory diseases such as rheumatoid arthritis and psoriatic arthritis. In October 2012 Covagen entered into a strategic research collaboration and license agreement with Mitsubishi Tanabe / TRL for the development of bispecific FynomAbs against target pairs selected by Mitsubishi Tanabe / TRL. Covagen was founded in 2007 as a spin-off company from ETH Zurich (Swiss Federal Institute of Technology). A strong syndicate of investors supports Covagen’s drug development programs including Novartis Venture Fund, Edmond de Rothschild Investment Partners, Gimv, Seroba Kernel Life Sciences, Ventech, Ascent Biomedical Venture Management, MP Healthcare Venture Management, and Baxter Ventures.
Jobs

Covagen hasn't added any jobs yet

Get notified when Covagen posts new jobs.

Find a startup job
Clara Albani
Avatar for Clara Albani
Research Associate at Covagen AG, one of the Janssen Pharmaceutical Companies of Johnson & Johnson
Total raised

$90.5M

Funded over

5 rounds

Latest round

Series B (Feb 2014)

Other Similar Companies Hiring
Wasatch Microfluidics company logo
Wasatch Microfluidics • Indiana • 6 days ago
Omeros company logo
Omeros • Seattle • $220k – $240k • 6 days ago
Ptc Therapeutics company logo
Ptc Therapeutics • United States • $119k – $145k • 3 weeks ago
Eli Lilly company logo
Eli Lilly • Indianapolis • $69k – $165k • 3 weeks ago